ANNUAL REPORT
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly Advik Laboratories Limited) has submitted its 31st Annual Report for FY 2024-25 along with the AGM notice to BSE. The 31st AGM is scheduled for Monday, 29th September 2025 at 09:30 AM at the registered office in Sohna, Haryana. Ordinary business includes adoption of audited financial statements and re-appointment of Managing Director Mr. Peeyush Kumar Aggarwal, who retires by rotation. Special business includes seeking shareholder approval for related party transactions up to Rs. 1,280 lakhs for FY 2025-26, covering unsecured loans from the promoter group entities and remuneration for the CFO and Company Secretary. The company also seeks approval to appoint M/s Kundan Agrawal & Associates as Secretarial Auditor for five years (FY 2025-26 to FY 2029-30). E-voting window runs from 26th September to 28th September 2025, with the cut-off date set as 22nd September 2025.
Routine regulatory filing — no immediate effect on stock price. Shareholders should review the related party transaction proposal (Rs. 1,280 lakhs with promoter-linked entities) and the director re-appointment, both of which require votes at the AGM. The book closure period is 23rd to 29th September 2025, so the ex-date / record date for AGM entitlement is 22nd September 2025.